Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Cook

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2024
Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax MeningitisJohn S Bradley, Jürgen B Bulitta, Rachel Cook, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation AnthraxEvelyn Lombarte Espinosa, María Cruz Villuendas Usón, Jorge Arribas García, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|November 14, 2023
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023William A Bower, Yon Yu, Marissa K Person, et al.
Blood Neoplasia|June 2, 2025
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trialTimothy S Pardee, Bayard L Powell, Richard A Larson, et al.
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMonzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
Global Change Biology|August 4, 2025
Improved Estimates of Biomass Expansion Factors and Root-To-Shoot Ratios: An Approach for Different Forest Types Across a Climatic Gradient in BrazilIsáira Leite E Lopes, Otávio Camargo Campoe, Geovanni Malatesta Barros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2024
Randomized Phase III SIERRA Trial of <sup>131</sup>I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AMLBoglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, et al.
Frontiers in Plant Science|April 1, 2026
A new use of Agrobacterium plant growth regulator genes for plant bioengineeringMichelle Heck, Marco Pitino, Samuel Coradetti, et al.
Journal of Personality and Social Psychology|November 14, 2024
A contest study to reduce attractiveness-based discrimination in social judgmentEliane Roy, Bastian Jaeger, Anthony M Evans, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 27, 2024
Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax MeningitisJohn S Bradley, Jürgen B Bulitta, Rachel Cook, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation AnthraxEvelyn Lombarte Espinosa, María Cruz Villuendas Usón, Jorge Arribas García, et al.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|November 14, 2023
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023William A Bower, Yon Yu, Marissa K Person, et al.
Blood Neoplasia|June 2, 2025
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trialTimothy S Pardee, Bayard L Powell, Richard A Larson, et al.
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2025
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationMonzr M Al Malki, Stephanie Bo-Subait, Brent Logan, et al.
Global Change Biology|August 4, 2025
Improved Estimates of Biomass Expansion Factors and Root-To-Shoot Ratios: An Approach for Different Forest Types Across a Climatic Gradient in BrazilIsáira Leite E Lopes, Otávio Camargo Campoe, Geovanni Malatesta Barros, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2024
Randomized Phase III SIERRA Trial of <sup>131</sup>I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AMLBoglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, et al.
Frontiers in Plant Science|April 1, 2026
A new use of Agrobacterium plant growth regulator genes for plant bioengineeringMichelle Heck, Marco Pitino, Samuel Coradetti, et al.
Journal of Personality and Social Psychology|November 14, 2024
A contest study to reduce attractiveness-based discrimination in social judgmentEliane Roy, Bastian Jaeger, Anthony M Evans, et al.
Pageof 5